You are here

Our science / Clinical Trials / Find a Trial / NCT00396448

Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.

Back to Search Print Save as PDF Bookmark Trial

NCT00396448

Last updated on February 20, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Peoria, Arizona, 85381 United States
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Obesity
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-70 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Obese adults with a body mass index > or = 30 kg/m ; > or = 27 kg/m2 for those with
obesity-related comorbidities including hypertension and dyslipidemia

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Pregnancy

- Diabetes

- Adults with serious or unstable current or past medical conditions

NCT00396448
Pfizer
Terminated
Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Obesity
A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety
NCT00375401
All Genders
18+
Years
Multiple Sites
Obesity
A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients
NCT00483171
All Genders
18+
Years
Multiple Sites
Morbid Obesity, Metabolic Disease
Study Evaluating Metabolic Syndrome in Subjects Undergoing Gastric Bypass Bariatric Syndrome
NCT00283374
All Genders
18+
Years
Multiple Sites
Obesity
Safety, Toleration and Efficacy of CP-741,952 for the Treatment of Obesity
NCT00367783
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now